Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Informed shared decision making in multiple sclerosis--inevitable or impossible?

C Heesen1, J Kasper, S Köpke

  • 1Institute of Neuroimmunology and Clinical Multiple Sclerosis Research INIMS, Hamburg-Eppendorf, Germany. heesen@uke.uni-hamburg.de

Journal of the Neurological Sciences
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunotherapy decision coaching for people with multiple sclerosis - Implementation of an interprofessional decision support programme into clinical practice.

Multiple sclerosis and related disorders·2026
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

This study developed decision aids for multiple sclerosis (MS) patients, finding they desire active roles in treatment choices. Evidence-based information empowers MS patients in shared decision-making for better health outcomes.

Area of Science:

  • Neurology
  • Health Psychology
  • Medical Decision Making

Background:

  • Multiple Sclerosis (MS) management involves critical decisions regarding relapse treatment and disease-modifying therapies.
  • Patients increasingly seek active participation in healthcare decisions, particularly given the partial effectiveness of current MS immunotherapies.
  • Pre-study research indicated 80% of MS patients desire autonomous treatment roles, yet possess limited risk awareness.

Purpose of the Study:

  • To develop and evaluate decision aids for key MS treatment decisions.
  • To assess the impact of evidence-based patient information on patient involvement in shared decision-making.
  • To understand MS patients' capacity to comprehend and utilize complex health information.

Main Methods:

  • Development of two decision aids using a phased approach for complex interventions.

Related Experiment Videos

  • A trial comparing a 4-hour education program on relapse management against an information leaflet for 150 MS patients.
  • A second trial with 298 MS patients evaluating evidence-based immunotherapy information's effect on decisional role preference and patient-physician encounters.

    • Main Results:

    • MS patients demonstrate a strong preference for autonomous roles in treatment decisions.
    • Patients are capable of understanding and integrating balanced, evidence-based complex health information.
    • The study is ongoing, with results expected in early 2007 to quantify the impact of patient education on decision-making participation.

    Conclusions:

    • Decision aids and evidence-based information are crucial for empowering MS patients in healthcare choices.
    • Effective patient education can enhance the shared decision-making process in MS management.
    • Further research will elucidate the extent to which tailored information influences patient engagement in treatment decisions.